Cases
-
Latest cases
Belgian Court of Appeal dismisses European Commission’s multi-million damages claim from elevators cartel
-
Latest cases
Compass Lexecon Veterinary Clients Obtain FTC Merger Clearance
Dr. Loren Smith Leads Multiple Compass Lexecon Teams
-
Latest cases
Complete victory for electrode manufacturer GrafTech in ICC arbitration on Long-Term Agreements
-
Latest cases
Vodafone and Three obtain CMA clearance for €17.5 billion UK mobile telecom JV
-
Latest cases
Compass Lexecon Client Centre Lane Partners Defeats Injunction Seeking to Prevent Business Relocation
Court Relies on the “Compelling” Testimony of Compass Lexecon Executive Vice President Dr. Loren K. Smith
-
Latest cases
Compass Lexecon Client the City of Baltimore Awarded Over $260 Million after Jury Determines that Opioid Distributors’ Conduct Contributed to a Public Nuisance
-
Latest cases
Green light for JD Sports to acquire French sportswear retailer Courir
-
Latest cases
Compass Lexecon Client, The Federal Trade Commission, Granted Preliminary Injunction Pausing the Proposed Merger of Tapestry and Capri
Court Relies Heavily on Testimony of Compass Lexecon Executive Vice President Dr. Loren K. Smith
Showing 1–14 of 14 results
-
08 Jan 2024
On December 14, 2023, Pfizer completed its $43 billion acquisition of Seagen – the largest M&A deal in biopharma since 2019. The deal closed after merger reviews by competition authorities around… -
23 Mar 2023
In September 2022, Parker-Hannifin Corporation (“Parker”) closed its acquisition of Meggitt PLC, after obtaining clearance from regulatory authorities. Compass Lexecon advised Parker during… -
17 Jan 2023
At the beginning of November 2022, US-based consumer water services company Culligan International completed its combination with Waterlogic Holdings, a B2B provider of drinking water dispensers,… -
06 Jul 2022
Compass Lexecon was retained by counsel at Wachtell, Lipton, Rosen, & Katz and Davis Polk & Wardell to represent the parties in connection with Creative Artists Agency’s acquisition of ICM… -
08 Sept 2019
Compass Lexecon assisted Liqui-Box in analyzing the competitive implications of the merger in both the UK and U.S.. Our regional teams collaborated to agree a consistent approach regarding the… -
19 Aug 2019
Compass Lexecon supported GlaxoSmithKline plc (GSK) and Pfizer Inc. in their multi-billion dollar merger of their consumer healthcare businesses, providing crucial economic analyses for… -
11 Jul 2019
On 27 June 2019, the European Commission unconditionally approved the acquisition of Red Hat by IBM at Phase I. The $34 billion transaction will be the largest software and third-largest tech… -
17 Jan 2019
In January 2019, Solenis and BASF completed the creation of a joint venture combining their global paper and water chemicals businesses, with a pro forma sales value of approximately $3 billion. -
23 Dec 2018
In December 2018, the European Commission approved the acquisition by which KME acquired MKM after a Phase II investigation. Compass Lexecon provided economic advice to MKM, advising mainly on… -
18 Nov 2018
In November 2018, the UK Competition & Markets Authority ("CMA") cleared the £26 million acquisition by AC Nielsen of the advertising intelligence division (AdIntel) of Ebiquity plc, after a… -
16 Mar 2018
Compass Lexecon helped Suzano Papel e Celulose secure regulatory approval for its acquisition of Fibria Celulose in the US, Europe, and China with expert economic analysis. -
-
21 Jan 2015
In January 2015, the European Commission cleared the $13 billion (£9.2 billion) transaction between GlaxoSmithKline (GSK) and Novartis, subject to conditions, after a Phase I investigation.… -
Our professionals
Compass Lexecon’s staff includes more than 850 employees, including professional consultants, analysts, and practice support personnel that span 23 offices across the globe.
